Genzyme Corporate Research Search Genzyme Websites
Patients and FamiliesHealth Care ProfessionalsAbout Genzyme Therapeutics
Fabry Community HomeFabry Community
Health Care Professional Overview
About Fabry Disease
Signs and Symptoms
Genetics of Fabry Disease
Diagnosing Fabry
Disease Monograph
Current Treatments
The Fabry Registry
Genzyme Support
Resources

Ophthalmologic Findings

Renal ImpactCardiac Dysfunction
Cerebrovascular ComplicationsPain
AngiokeratomasHypohidrosis/Anhidrosis
Ophthalmologic FindingsHeat and Cold Intolerance
Gastrointestinal Manifestations 

Common ophthalmologic findings in Fabry disease include:

  • Whorled corneal opacities
  • Lenticular opacities
  • Vascular lesions of the conjunctivae and retina

Corneal opacities

Corneal opacities, beginning with a diffuse haziness and progressing to a characteristic “whorled” or “spoke-like” pattern, are found almost universally among classically affected hemizygotes and in a high proportion of heterozygous females (estimated to be approximately 70% [1]). This finding can be visualized through slit lamp microscopy. Corneal opacities do not impair vision.[2]

Distinctive Corneal Opacity in Fabry Disease

Lenticular opacities

Two types of lens opacities have been noted in Fabry patients: cream-colored anterior capsular deposits in the lens (sometimes distributed like a propeller), and whitish, granular spoke-like deposits on the posterior lens (referred to as Fabry cataracts). Fabry cataracts are more commonly observed than capsular deposits; they can be visualized by retroillumination.[2]

Lesions

Conjunctival and retinal vascular lesions resulting from the generalized disease process are common.[1]

Typical Conjunctival Involvement in Fabry Disease

Lesions may appear to be sausage-like, with markedly dilated vessels. The presence of several lesions of this type, which do not affect vision, may be pathognomonic for Fabry disease.[1]

To view a list of articles related to ophthalmologic findings in Fabry disease, click here.

References

1. Desnick RJ, Ioannou YA, Eng CM. Alpha-galactosidase A deficiency: Fabry disease. In: The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw Hill, 2001;3733-3774.

2. Sher NA, Letson RD, Desnick RJ. The ocular manifestations in Fabry’s disease. Arch Ophthalmol. 1979;97:671-676.

Keyword: 
Search In: 
New Page 1
Fabry Voices
""

More Fabry patient profiles
Resources
Medical Information Services
Request Materials
Publications
Events Calendar
Related Links
Fabry Registry

First Symptoms to Diagnosis

Data from the Fabry Registry confirms the large gap between the average age of symptoms onset (10.5) and diagnosis of Fabry disease (28.5). To learn more about the importance of the Fabry Registry click here.

Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142
617 768 9000
800 745 4447

Genzyme Europe BV
Gooimeer 10
1411 DD Naarden
The Netherlands
31 35 699 1200
Contact Genzyme


Terms and Conditions of Use | Privacy Policy | © 2003-2009 Genzyme Corporation. All rights reserved.| © Fabr/US/P219/08/05
Genzyme Therapeutics